Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut Syndrome

NCT: NCT06464653 · ACTIVE_NOT_RECRUITING

NCT IDNCT06464653
StatusACTIVE_NOT_RECRUITING
Start Date2024-05-01
Completion2026-12-30

Brief Summary

The primary objective of this research is to study the efficacy and safety of deep brain stimulation (DBS) of pallidothalamic tracts as adjunctive therapy for alleviating symptoms in Lennox-Gastaut Syndrome.

Frequently Asked Questions

What is Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut Syndrome?

Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut Syndrome is a clinical trial registered under NCT06464653. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06464653?

The current status of NCT06464653 (Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut Syndrome) is: ACTIVE_NOT_RECRUITING.

When did Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut Syndrome start?

Pallidothalamic Tracts Electrical Stimulation for Lennox-Gastaut Syndrome started on 2024-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑